BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 416960)

  • 1. Effects of methysergide, pizotifen and ergotamine in the monkey cranial circulation.
    Mylecharane EJ; Spira PJ; Misbach J; Duckworth JW; Lance JW
    Eur J Pharmacol; 1978 Mar; 48(1):1-9. PubMed ID: 416960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of humoral agents and antimigraine drugs on the cranial circulation of the monkey.
    Spira PJ; Mylecharane EJ; Lance JW
    Res Clin Stud Headache; 1976; 4():37-75. PubMed ID: 818690
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of drugs applicable to treatment of migraine in the cranial circulation of the monkey.
    Lance JW; Spira PJ; Mylecharane EJ; Lord GD; Duckworth JW
    Res Clin Stud Headache; 1978; 6():13-8. PubMed ID: 103151
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of pizotifen and ergotamine on the venoconstrictor effect of 5-hydroxytryptamine and noradrenaline in man.
    Aellig WH
    Eur J Clin Pharmacol; 1983; 25(6):759-62. PubMed ID: 6662174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of four migraine prophylactic drugs on an isolated extracranial artery.
    Fozard JR
    Eur J Pharmacol; 1976 Mar; 36(1):127-139. PubMed ID: 1261590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta.
    Apperley E; Humphrey PP; Levy GP
    Br J Pharmacol; 1976 Oct; 58(2):211-21. PubMed ID: 184872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of low doses of clonidine in the monkey cranial circulation.
    Mylecharane EJ; Duckworth JW; Lord GD; Lance JW
    Eur J Pharmacol; 1980 Nov; 68(2):163-73. PubMed ID: 7202484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the 5-HT receptor in vascular smooth muscle.
    Müller-Schweinitzer E
    Res Clin Stud Headache; 1978; 6():6-12. PubMed ID: 725257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of antimigraine drugs on the vascular responses by-5-hydroxytryptamine and related biogenic substances on the external carotid bed of dogs: possible pharmacological implications to their antimigraine action.
    Saxena PR
    Headache; 1972 Jul; 12(2):44-54. PubMed ID: 5056178
    [No Abstract]   [Full Text] [Related]  

  • 10. Internal and external carotid vascular responses to vasoactive agents in the monkey.
    Spira PJ; Mylecharane EJ; Misbach J; Duckworth JW; Lance JW
    Neurology; 1978 Feb; 28(2):162-73. PubMed ID: 414152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ergotamine-induced constriction of cranial arteriovenous anastomoses in dogs pretreated with phentolamine and pizotifen.
    Saxena PR; Koedam NA; Heiligers J; Hof RP
    Cephalalgia; 1983 Jun; 3(2):71-81. PubMed ID: 6409416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine--studies in an experimental model for migraine.
    Saxena PR; de Vlaam-Schluter GM
    Headache; 1974 Jan; 13(4):142-63. PubMed ID: 4149297
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for stimulation of 5-HT receptors in canine saphenous arteries by ergotamine.
    Müller-Schweinitzer E
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):41-4. PubMed ID: 1004641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels. Possible implications in migraine.
    Hardebo JE; Edvinsson L; Owman C; Svendgaard NA
    Neurology; 1978 Jan; 28(1):64-70. PubMed ID: 563539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
    Villalón CM; De Vries P; Rabelo G; Centurión D; Sánchez-López A; Saxena P
    Br J Pharmacol; 1999 Feb; 126(3):585-94. PubMed ID: 10188968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pizotifen, an antimigraine drug with venoconstrictor activity in vivo.
    Müller-Schweinitzer E
    J Cardiovasc Pharmacol; 1986; 8(4):805-10. PubMed ID: 2427822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Classification, pathogenesis and drug therapy of migraine and related forms of headache].
    Fanchamps A
    Med Welt; 1975 Aug; 6(35):1518-23. PubMed ID: 241000
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
    Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
    Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of action of drugs currently used in the prevention of migraine].
    Fanchamps A
    Minerva Med; 1976 Jun; 67(28):1858-60. PubMed ID: 59325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade by phentolamine of the potentiation of histamine-induced vasoconstriction caused by serotonin and methysergide in the rabbit ear artery.
    Carroll PR; Morgans D; Glover WE
    Clin Exp Pharmacol Physiol; 1977; 4(1):43-8. PubMed ID: 884902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.